Microbiome Sequencing Market: By Technology, Sequencing by Ligation, Targeted Gene Sequencing Others), By Application, By Research Type, By End User and Geography

Microbiome Sequencing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technology (Shotgun Sequencing, Sequencing by Synthesis (SBS), Sequencing by Ligation (SBL), Targeted Gene Sequencing Others), By Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology Other), By Research Type (Outsourced Research, Internal Research), By End User (Pharmaceutical and Biotechnology Companies, Academia/Research Institutes, Contract Research organizations) and Region

Microbiome Sequencing Market was valued at US$ 1.71 billion in 2023 and is poised to grow at a 6.7% CAGR from 2024- 2030. The market for microbiome sequencing services is expanding due in large part to the rising demand for Next-Generation Sequencing. For example, next-generation sequencing (NGS) technology has advanced our understanding of the human microbiome by enabling the discovery and characterization of unculturable microbes with function predictions, according to a paper published in the Journal of Clinical Investigation in April 2022. The market for next-generation sequencing services is anticipated to increase at a faster rate because of these innovations. The market for microbiome sequencing services is expected to develop over the forecast period due in part to the global upsurge in genomic research. For example, data on genomic data science updated in April 2022 by the National Human Genome Research Institute of the United States National Institute of Health showed that the amount of genomic data generated is growing annually, ranging from 2 to 40 billion gigabytes, in tandem with the rapid expansion of large-scale collaborations and biomedical research projects.

The market for microbiome sequencing services is expanding because of numerous genomic research R&D initiatives. Additionally, the spike in gut research based on genomics and the increasing demand for Next-generation Sequencing (NGS) are the main factors driving the market expansion. All the bacteria, fungi, viruses, and protists that are present in and on the human body as well as in the environment are collectively referred to as the microbiome. Researchers are employing metagenomics sequencing, which involves the continuous sequencing of genetic information from many organisms, to identify the bacteria that comprise a certain microbiome. Therefore, it is anticipated that the previously mentioned elements—such as the expansion of genomic research, advancements in NGS technology, and the growing innovations made by industry participants—will spur market expansion. The shortage of qualified specialists for NGS data analysis and ethical and legal concerns surrounding genome sequencing, however, are impeding the market's expansion for microbiome sequencing services throughout the projected timeframe.

Microbiome Sequencing Market Key Developments:
  • In November 2023, QIAGEN NV introduced the Microbiome WGS (whole-genome sequencing) SeqSets, a full workflow from Sample to Insight that is meant to maximize efficiency and reproducibility in microbiome research while being user-friendly.
  • June 2023: Zymo Research launched its full-length 16S sequencing service offering researchers high-quality, full-length 16S rRNA gene sequencing for microbiome analysis.

Microbiome Sequencing Market Summary

Study Period

2024 - 2030

Base Year

2023

CAGR

6.7%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Microbiome sequencing Market Dynamics

The growth and innovation of the pharmaceutical industry to launch microbiome sequencing services due to the huge health-conscious consumers is creating an opportunity for the microbiome sequencing market. Microbiome sequencing market growth is expected to be supported by emerging markets due to the availability of improved healthcare infrastructure, increasing unmet healthcare needs, increasing prevalence of chronic diseases in adults, and growing demand for next-generation sequencing technology. Market growth of Microbiome Sequencing is driven by increase in the number of R&D institutions in the biological field due to genomic research and the prevalence of chronic diseases. The factor is expected to drive the growth of the market are the increasing demand due to the expansion of next generation sequencing for microbiome sequencing services, its implementation and reduction of sequencing costs. Surge in awareness and benefits of microbiome sequencing in cancer treatment is expected to fuel the market. For example, according to an article published in the journal BMC 2021, microbiome sequencing has been used to understand tissue microbiome composition and has been useful in predicting colorectal cancer prognosis using 16S rRNA amplicon sequencing. In addition, the increased use of the human microbiome for drug development and the use of sequencing technologies for the development of personalized medicine are expected to stimulate the growth of the microbiome sequencing market.

Rising prevalence of chronic diseases will significantly affect the microbiome sequencing market forecast. Various organizations, including the government, advise people about microbiome sequencing applications. Factors such as increased adoption of microbiome sequencing and growing awareness about the use of sequencing are driving the growth of the market. In addition, increased promotional efforts by manufacturers, increased awareness of the microbiome, and increased demand for next-generation sequencing of the population are expected to drive their adoption in the near future. However, factor such as lack of skilled personnel in operating system is limiting the growth of microbiome sequencing market. Additionally, stringent regulations and government regulations on microbiome sequencing may also hamper the market growth. Conversely, advances in the development of efficient sequencing services and the need for next-generation sequencing technology provide lucrative opportunities for market players.

Microbiome Sequencing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024 - 2030

Market Size in 2023

US$ 1.71 billion

Market CAGR

6.7%

By Technology

  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Shotgun Sequencing
  • Targeted Gene Sequencing
  • Other Technologies

By Application

  • Gastrointestinal Diseases
  • Infectious Diseases
  • CNS Diseases
  • Oncology
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institutes
  • Others

Key Features of the Report

  • The report provides granular level information about the Market size, regional Market share, historic Market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key Market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the Market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the Market.
  • The report provides a plethora of information about Market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

The Microbiome sequencing Market was valued at US$ 1.71 billion in 2023 and is poised to grow at a CAGR of 6.7 %.

Microbiome sequencing key factors driving market growth include increased genomic research and microbiome sequencing applications, as well as rapid adoption of NGS in emerging economies.

The future trends in the market are the use of microbiome sequencing in the early diagnosis of diseases and the use of this technology in the development of individualized medicines for various diseases.

RNA sequencing is the leading technology in the microbiome sequencing market.

Market research is segmented based on technology, application , end user and region.

Asain-Pacific is expected to fastest-growing region in the Microbiome sequencing Market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Microbiome Sequencing Market Introduction
2.1. Global Microbiome Sequencing Market – Taxonomy
2.2. Global Microbiome Sequencing Market –Definitions
2.2.1. Technology
2.2.2. Application
2.2.3. Research Type
2.2.4. End User
3. Global Microbiome Sequencing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Microbiome Sequencing Market Dynamic Factors - Impact Analysis
3.6. Global Microbiome Sequencing Market – Competition Landscape
4. Global Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Microbiome Sequencing Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1. Shotgun Sequencing
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Sequencing by Synthesis (SBS)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Sequencing by Ligation (SBL)
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Targeted Gene Sequencing
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Microbiome Sequencing Market, By Application, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1. Gastrointestinal Diseases
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Infectious Diseases
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. CNS Diseases
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Oncology
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Other
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Microbiome Sequencing Market, By Research Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1. Outsourced Research
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Internal Research
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Microbiome Sequencing Market, By End User Industry, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Academia/Research Institutes
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Contract Research organizations
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Microbiome Sequencing Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Region, 2024 - 2030
10. North America Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
10.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Shotgun Sequencing
10.1.2. Sequencing by Synthesis (SBS)
10.1.3. Sequencing by Ligation (SBL)
10.1.4. Targeted Gene Sequencing
10.1.5. Others
10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Gastrointestinal Diseases
10.2.2. Infectious Diseases
10.2.3. CNS Diseases
10.2.4. Oncology
10.2.5. Other
10.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Outsourced Research
10.3.2. Internal Research
10.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Academia/Research Institutes
10.4.3. Contract Research organizations
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030
10.7. North America Microbiome Sequencing Market Dynamics – Trends
11. Europe Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
11.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Shotgun Sequencing
11.1.2. Sequencing by Synthesis (SBS)
11.1.3. Sequencing by Ligation (SBL)
11.1.4. Targeted Gene Sequencing
11.1.5. Others
11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Gastrointestinal Diseases
11.2.2. Infectious Diseases
11.2.3. CNS Diseases
11.2.4. Oncology
11.2.5. Other
11.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Outsourced Research
11.3.2. Internal Research
11.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Academia/Research Institutes
11.4.3. Contract Research organizations
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030
11.7. Europe Microbiome Sequencing Market Dynamics – Trends
12. Asia-Pacific Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
12.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Shotgun Sequencing
12.1.2. Sequencing by Synthesis (SBS)
12.1.3. Sequencing by Ligation (SBL)
12.1.4. Targeted Gene Sequencing
12.1.5. Others
12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Gastrointestinal Diseases
12.2.2. Infectious Diseases
12.2.3. CNS Diseases
12.2.4. Oncology
12.2.5. Other
12.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Outsourced Research
12.3.2. Internal Research
12.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Academia/Research Institutes
12.4.3. Contract Research organizations
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030
12.7. Asia-Pacific Microbiome Sequencing Market Dynamics – Trends
13. Latin America Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
13.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Shotgun Sequencing
13.1.2. Sequencing by Synthesis (SBS)
13.1.3. Sequencing by Ligation (SBL)
13.1.4. Targeted Gene Sequencing
13.1.5. Others
13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Gastrointestinal Diseases
13.2.2. Infectious Diseases
13.2.3. CNS Diseases
13.2.4. Oncology
13.2.5. Other
13.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Outsourced Research
13.3.2. Internal Research
13.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Academia/Research Institutes
13.4.3. Contract Research organizations
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030
13.7. Latin America Microbiome Sequencing Market Dynamics – Trends
14. Middle East and Africa Microbiome Sequencing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn)
14.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Shotgun Sequencing
14.1.2. Sequencing by Synthesis (SBS)
14.1.3. Sequencing by Ligation (SBL)
14.1.4. Targeted Gene Sequencing
14.1.5. Others
14.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Gastrointestinal Diseases
14.2.2. Infectious Diseases
14.2.3. CNS Diseases
14.2.4. Oncology
14.2.5. Other
14.3. Research Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Outsourced Research
14.3.2. Internal Research
14.4. End User Industry Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Academia/Research Institutes
14.4.3. Contract Research organizations
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Microbiome Sequencing Market - Opportunity Analysis Index, By Technology, By Application, By Research Type, By End User Industry, and Country, 2024 - 2030
14.7. MEA Microbiome Sequencing Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Technologies, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Baseclear BV
15.2.2. Clinical Microbiomics AS
15.2.3. Merieux Nutrisciences Corporations
15.2.4. EPIBIOME
15.2.5. Microbiome Insights Inc
15.2.6. Microbiome Therapeutics LLC
15.2.7. MR DNA
15.2.8. Second Genome
15.2.9. Ubiome Inc.
15.2.10. Clear Labs
16. Research Methodology
17. Key Assumptions and Acronyms

Key Market Players

  • Baseclear B.V.
  • Microbiome Insights
  • Clinical Microbiomics
  • CosmosID
  • Novogene Co., Ltd.
  • Charles River Laboratories International, Inc.
  • OraSure Technologies (Diversigen)
  • Zymo Research Corporation
  • Resphera Biosciences
  • Molecular Research LP
  • Merieux Nutrisciences Corporations (Biofortis)
  • Locus Biosciences (EPIBIOME)
  • MR DNA
  • Rancho Biosciences
  • Metabiomics
  • ZIFO
  • Shanghai Realbio Technology (RBT) Co., Ltd.

Related Industry Reports